Authors
Loading...
Observational analysis reveals TET2 mutations lead to skewed iNKT differentiation and inflammation in hematopoietic cells, indicating novel immunometabolic targets for therapy.
Goel et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: